Compare HCAT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCAT | TMCI |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.0M | 120.4M |
| IPO Year | 2019 | 2021 |
| Metric | HCAT | TMCI |
|---|---|---|
| Price | $2.29 | $4.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 6 |
| Target Price | $2.53 | ★ $4.77 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $311,136,000.00 | $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 1.48 | ★ 1.59 |
| 52 Week Low | $0.96 | $1.17 |
| 52 Week High | $4.12 | $7.78 |
| Indicator | HCAT | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 72.08 | 55.98 |
| Support Level | $2.23 | $3.84 |
| Resistance Level | $2.35 | $4.62 |
| Average True Range (ATR) | 0.15 | 0.41 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 87.67 | 52.66 |
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.